시장조사 보고서 : 세계의 혈액 종양 검사 시장예측 2021년-2026년

■ 영문 제목 : Global Hemato Oncology Testing Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K00211 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 99 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 혈액 종양 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (ctDNA 검사, CTC 검사, 기타)와 용도별 시장규모 (병원, 제3 기관, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 혈액 종양 검사 시장 점유율
- 지역별 혈액 종양 검사 시장규모
- 주요지역의 종류별 시장규모 (ctDNA 검사, CTC 검사, 기타)
- 주요지역의 용도별 시장규모 (병원, 제3 기관, 기타)
- 미주의 혈액 종양 검사 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 혈액 종양 검사 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 혈액 종양 검사 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 혈액 종양 검사 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 혈액 종양 검사 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Roche, Berry Genomics, Burning Rock Dx, BGI, Genetron, Haplox, Amoy Dx, Genosaber, YZY Biopharma, Wondfo
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Hemato Oncology Testing will have significant change from previous year. By the most conservative estimates of global Hemato Oncology Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hemato Oncology Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemato Oncology Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
ctDNA Testing
CTC Testing
Other Testing

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital
Third Party Agency
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Berry Genomics
Burning Rock Dx
BGI
Genetron
Haplox
Amoy Dx
Genosaber
YZY Biopharma
Wondfo

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemato Oncology Testing Market Size 2016-2026
2.1.2 Hemato Oncology Testing Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Hemato Oncology Testing Segment by Type
2.2.1 ctDNA Testing
2.2.2 ctDNA Testing
2.2.3 Other Testing
2.3 Hemato Oncology Testing Market Size by Type
2.3.1 Global Hemato Oncology Testing Market Size CAGR by Type
2.3.2 Global Hemato Oncology Testing Market Size Market Share by Type (2016-2021)
2.4 Hemato Oncology Testing Segment by Application
2.4.1 Hospital
2.4.2 Third Party Agency
2.4.3 Others
2.5 Hemato Oncology Testing Market Size by Application
2.5.1 Global Hemato Oncology Testing Market Size CAGR by Application
2.5.2 Global Hemato Oncology Testing Market Size Market Share by Application (2016-2021)

3 Hemato Oncology Testing Market Size by Players
3.1 Hemato Oncology Testing Market Size Market Share by Players
3.1.1 Global Hemato Oncology Testing Revenue by Players (2019-2021E)
3.1.2 Global Hemato Oncology Testing Revenue Market Share by Players (2019-2021E)
3.2 Global Hemato Oncology Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Hemato Oncology Testing by Regions
4.1 Hemato Oncology Testing Market Size by Regions (2016-2021)
4.2 Americas Hemato Oncology Testing Market Size Growth (2016-2021)
4.3 APAC Hemato Oncology Testing Market Size Growth (2016-2021)
4.4 Europe Hemato Oncology Testing Market Size Growth (2016-2021)
4.5 Middle East & Africa Hemato Oncology Testing Market Size Growth (2016-2021)

5 Americas
5.1 Americas Hemato Oncology Testing Market Size by Country (2016-2021)
5.2 Americas Hemato Oncology Testing Market Size by Type (2016-2021)
5.3 Americas Hemato Oncology Testing Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hemato Oncology Testing Market Size by Region (2016-2021)
6.2 APAC Hemato Oncology Testing Market Size by Type (2016-2021)
6.3 APAC Hemato Oncology Testing Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hemato Oncology Testing by Country (2016-2021)
7.2 Europe Hemato Oncology Testing Market Size by Type (2016-2021)
7.3 Europe Hemato Oncology Testing Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hemato Oncology Testing by Region (2016-2021)
8.2 Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2021)
8.3 Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Hemato Oncology Testing Market Forecast
10.1 Global Hemato Oncology Testing Forecast by Regions (2021-2026)
10.1.1 Global Hemato Oncology Testing Forecast by Regions (2021-2026)
10.1.2 Americas Hemato Oncology Testing Forecast
10.1.3 APAC Hemato Oncology Testing Forecast
10.1.4 Europe Hemato Oncology Testing Forecast
10.1.5 Middle East & Africa Hemato Oncology Testing Forecast
10.2 Americas Hemato Oncology Testing Forecast by Countries (2021-2026)
10.2.1 United States Hemato Oncology Testing Market Forecast
10.2.2 Canada Hemato Oncology Testing Market Forecast
10.2.3 Mexico Hemato Oncology Testing Market Forecast
10.2.4 Brazil Hemato Oncology Testing Market Forecast
10.3 APAC Hemato Oncology Testing Forecast by Region (2021-2026)
10.3.1 China Hemato Oncology Testing Market Forecast
10.3.2 Japan Hemato Oncology Testing Market Forecast
10.3.3 Korea Hemato Oncology Testing Market Forecast
10.3.4 Southeast Asia Hemato Oncology Testing Market Forecast
10.3.5 India Hemato Oncology Testing Market Forecast
10.3.6 Australia Hemato Oncology Testing Market Forecast
10.4 Europe Hemato Oncology Testing Forecast by Country (2021-2026)
10.4.1 Germany Hemato Oncology Testing Market Forecast
10.4.2 France Hemato Oncology Testing Market Forecast
10.4.3 UK Hemato Oncology Testing Market Forecast
10.4.4 Italy Hemato Oncology Testing Market Forecast
10.4.5 Russia Hemato Oncology Testing Market Forecast
10.5 Middle East & Africa Hemato Oncology Testing Forecast by Region (2021-2026)
10.5.1 Egypt Hemato Oncology Testing Market Forecast
10.5.2 South Africa Hemato Oncology Testing Market Forecast
10.5.3 Israel Hemato Oncology Testing Market Forecast
10.5.4 Turkey Hemato Oncology Testing Market Forecast
10.5.5 GCC Countries Hemato Oncology Testing Market Forecast
10.6 Global Hemato Oncology Testing Forecast by Type (2021-2026)
10.7 Global Hemato Oncology Testing Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Hemato Oncology Testing Product Offered
11.1.3 Roche Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Berry Genomics
11.2.1 Berry Genomics Company Information
11.2.2 Berry Genomics Hemato Oncology Testing Product Offered
11.2.3 Berry Genomics Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Berry Genomics Main Business Overview
11.2.5 Berry Genomics Latest Developments
11.3 Burning Rock Dx
11.3.1 Burning Rock Dx Company Information
11.3.2 Burning Rock Dx Hemato Oncology Testing Product Offered
11.3.3 Burning Rock Dx Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Burning Rock Dx Main Business Overview
11.3.5 Burning Rock Dx Latest Developments
11.4 BGI
11.4.1 BGI Company Information
11.4.2 BGI Hemato Oncology Testing Product Offered
11.4.3 BGI Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 BGI Main Business Overview
11.4.5 BGI Latest Developments
11.5 Genetron
11.5.1 Genetron Company Information
11.5.2 Genetron Hemato Oncology Testing Product Offered
11.5.3 Genetron Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Genetron Main Business Overview
11.5.5 Genetron Latest Developments
11.6 Haplox
11.6.1 Haplox Company Information
11.6.2 Haplox Hemato Oncology Testing Product Offered
11.6.3 Haplox Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Haplox Main Business Overview
11.6.5 Haplox Latest Developments
11.7 Amoy Dx
11.7.1 Amoy Dx Company Information
11.7.2 Amoy Dx Hemato Oncology Testing Product Offered
11.7.3 Amoy Dx Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Amoy Dx Main Business Overview
11.7.5 Amoy Dx Latest Developments
11.8 Genosaber
11.8.1 Genosaber Company Information
11.8.2 Genosaber Hemato Oncology Testing Product Offered
11.8.3 Genosaber Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Genosaber Main Business Overview
11.8.5 Genosaber Latest Developments
11.9 YZY Biopharma
11.9.1 YZY Biopharma Company Information
11.9.2 YZY Biopharma Hemato Oncology Testing Product Offered
11.9.3 YZY Biopharma Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 YZY Biopharma Main Business Overview
11.9.5 YZY Biopharma Latest Developments
11.10 Wondfo
11.10.1 Wondfo Company Information
11.10.2 Wondfo Hemato Oncology Testing Product Offered
11.10.3 Wondfo Hemato Oncology Testing Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Wondfo Main Business Overview
11.10.5 Wondfo Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Hemato Oncology Testing Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of ctDNA Testing
Table 3. Major Players of CTC Testing
Table 4. Major Players of Other Testing
Table 5. Hemato Oncology Testing Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Hemato Oncology Testing Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Hemato Oncology Testing Market Size Market Share by Type (2016-2021)
Table 8. Hemato Oncology Testing Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Hemato Oncology Testing Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Hemato Oncology Testing Market Size Market Share by Application (2016-2021)
Table 11. Global Hemato Oncology Testing Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Hemato Oncology Testing Revenue Market Share by Players (2019-2021E)
Table 13. Hemato Oncology Testing Key Players Head office and Products Offered
Table 14. Hemato Oncology Testing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hemato Oncology Testing Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Hemato Oncology Testing Market Size Market Share by Regions 2016-2021
Table 19. Americas Hemato Oncology Testing Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Hemato Oncology Testing Market Size Market Share by Country (2016-2021)
Table 21. Americas Hemato Oncology Testing Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Hemato Oncology Testing Market Size Market Share by Type (2016-2021)
Table 23. Americas Hemato Oncology Testing Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Hemato Oncology Testing Market Size Market Share by Application (2016-2021)
Table 25. APAC Hemato Oncology Testing Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Hemato Oncology Testing Market Size Market Share by Region (2016-2021)
Table 27. APAC Hemato Oncology Testing Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Hemato Oncology Testing Market Size Market Share by Type (2016-2021)
Table 29. APAC Hemato Oncology Testing Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Hemato Oncology Testing Market Size Market Share by Application (2016-2021)
Table 31. Europe Hemato Oncology Testing Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Hemato Oncology Testing Market Size Market Share by Country (2016-2021)
Table 33. Europe Hemato Oncology Testing Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Hemato Oncology Testing Market Size Market Share by Type (2016-2021)
Table 35. Europe Hemato Oncology Testing Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Hemato Oncology Testing Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Hemato Oncology Testing Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Hemato Oncology Testing Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Hemato Oncology Testing Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Hemato Oncology Testing Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Hemato Oncology Testing
Table 44. Key Application and Potential Industries of Hemato Oncology Testing
Table 45. Key Challenges of Hemato Oncology Testing
Table 46. Key Trends of Hemato Oncology Testing
Table 47. Global Hemato Oncology Testing Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Hemato Oncology Testing Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Hemato Oncology Testing Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Hemato Oncology Testing Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Hemato Oncology Testing Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Hemato Oncology Testing Market Size Market Share Forecast by Application (2021-2026)
Table 53. Roche Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 54. Roche Hemato Oncology Testing Product Offered
Table 55. Roche Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. Berry Genomics Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 59. Berry Genomics Hemato Oncology Testing Product Offered
Table 60. Berry Genomics Main Business
Table 61. Berry Genomics Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Berry Genomics Latest Developments
Table 63. Burning Rock Dx Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 64. Burning Rock Dx Hemato Oncology Testing Product Offered
Table 65. Burning Rock Dx Main Business
Table 66. Burning Rock Dx Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Burning Rock Dx Latest Developments
Table 68. BGI Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 69. BGI Hemato Oncology Testing Product Offered
Table 70. BGI Main Business
Table 71. BGI Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. BGI Latest Developments
Table 73. Genetron Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 74. Genetron Hemato Oncology Testing Product Offered
Table 75. Genetron Main Business
Table 76. Genetron Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Genetron Latest Developments
Table 78. Haplox Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 79. Haplox Hemato Oncology Testing Product Offered
Table 80. Haplox Main Business
Table 81. Haplox Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Haplox Latest Developments
Table 83. Amoy Dx Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 84. Amoy Dx Hemato Oncology Testing Product Offered
Table 85. Amoy Dx Main Business
Table 86. Amoy Dx Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Amoy Dx Latest Developments
Table 88. Genosaber Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 89. Genosaber Hemato Oncology Testing Product Offered
Table 90. Genosaber Main Business
Table 91. Genosaber Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Genosaber Latest Developments
Table 93. YZY Biopharma Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 94. YZY Biopharma Hemato Oncology Testing Product Offered
Table 95. YZY Biopharma Main Business
Table 96. YZY Biopharma Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. YZY Biopharma Latest Developments
Table 98. Wondfo Details, Company Type, Hemato Oncology Testing Area Served and Its Competitors
Table 99. Wondfo Hemato Oncology Testing Product Offered
Table 100. Wondfo Main Business
Table 101. Wondfo Hemato Oncology Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Wondfo Latest Developments
List of Figures
Figure 1. Hemato Oncology Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hemato Oncology Testing Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Hemato Oncology Testing Market Size Market Share by Type in 2020
Figure 7. Hemato Oncology Testing in Hospital
Figure 8. Global Hemato Oncology Testing Market: Hospital (2016-2021) & ($ Millions)
Figure 9. Hemato Oncology Testing in Third Party Agency
Figure 10. Global Hemato Oncology Testing Market: Third Party Agency (2016-2021) & ($ Millions)
Figure 11. Hemato Oncology Testing in Others
Figure 12. Global Hemato Oncology Testing Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Hemato Oncology Testing Market Size Market Share by Application in 2020
Figure 14. Global Hemato Oncology Testing Revenue Market Share by Player in 2020
Figure 15. Global Hemato Oncology Testing Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Hemato Oncology Testing Market Size 2016-2021 ($ Millions)
Figure 17. APAC Hemato Oncology Testing Market Size 2016-2021 ($ Millions)
Figure 18. Europe Hemato Oncology Testing Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Hemato Oncology Testing Market Size 2016-2021 ($ Millions)
Figure 20. Americas Hemato Oncology Testing Market Size Market Share by Country in 2020
Figure 21. Americas Hemato Oncology Testing Market Size Market Share by Type in 2020
Figure 22. Americas Hemato Oncology Testing Market Size Market Share by Application in 2020
Figure 23. United States Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Hemato Oncology Testing Market Size Market Share by Regions in 2020
Figure 27. APAC Hemato Oncology Testing Market Size Market Share by Type in 2020
Figure 28. APAC Hemato Oncology Testing Market Size Market Share by Application in 2020
Figure 29. China Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Hemato Oncology Testing Market Size Market Share by Country in 2020
Figure 36. Europe Hemato Oncology Testing Market Size Market Share by Type in 2020
Figure 37. Europe Hemato Oncology Testing Market Size Market Share by Application in 2020
Figure 38. Germany Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Hemato Oncology Testing Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Hemato Oncology Testing Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Hemato Oncology Testing Market Size Market Share by Application in 2020
Figure 46. Egypt Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Hemato Oncology Testing Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 52. APAC Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 53. Europe Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 55. United States Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 56. Canada Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 59. China Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 60. Japan Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 61. Korea Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 63. India Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 64. Australia Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 65. Germany Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 66. France Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 67. UK Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 68. Italy Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 69. Russia Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 70. Spain Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 73. Israel Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Hemato Oncology Testing Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Hemato Oncology Testing Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 혈액 종양 검사 시장예측 2021년-2026년] (코드 : LPI-2201K00211) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 혈액 종양 검사 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 면역종양학 시장예측 2021년-2026년
LPI-2201K00152 / LP Information / 2021년 12월 / 본 조사보고서는 면역종양학의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Immuno-Oncology will have significant change from previous year. By the most conservative estimates of global Immuno-Oncology market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 37120 million in 2020. Over the next...

세계의 면역종양학 임상시험 시장예측 2021년-2026년
LPI-2201K00153 / LP Information / 2021년 12월 / 본 조사보고서는 면역종양학 임상시험의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Immuno-oncology Clinical Trials will have significant change from previous year. By the most conservative estimates of global Immuno-oncology Clinical Trials market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in...

세계의 종양학 기반 전임상 CRO 시장예측 2021년-2026년
LPI-2201K02249 / LP Information / 2021년 12월 / 본 조사보고서는 종양학 기반 전임상 CRO의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Oncology Based Preclinical CRO will have significant change from previous year. By the most conservative estimates of global Oncology Based Preclinical CRO market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 331.8...

세계의 종양 치료용 약물 시장예측 2021년-2026년
LPI-2201K02116 / LP Information / 2021년 12월 / 본 조사보고서는 종양 치료용 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Oncology Drugs will have significant change from previous year. By the most conservative estimates of global Oncology Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 174700 million in 2020. Over...

세계의 약사 미승인 검사 (LDT) 시장예측 2021년-2026년
LPI-2201K00165 / LP Information / 2021년 12월 / 본 조사보고서는 약사 미승인 검사 (LDT)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Laboratory-developed Testing will have significant change from previous year. By the most conservative estimates of global Laboratory-developed Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3316.2 million in 2020. Over...

세계의 HPV 검사 시장예측 2021년-2026년
LPI-2201K00134 / LP Information / 2021년 12월 / 본 조사보고서는 HPV 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of HPV Testing will have significant change from previous year. By the most conservative estimates of global HPV Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 724.9 million in 2020. Over...

세계의 PD-L1 및 PIK3CA 테스트 시장예측 2021년-2026년
LPI-2201K02136 / LP Information / 2021년 12월 / 본 조사보고서는 PD-L1 및 PIK3CA 테스트의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of PD-L1 and PIK3CA Testing will have significant change from previous year. By the most conservative estimates of global PD-L1 and PIK3CA Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 396.6...

세계의 POC HbA1C 검사 시장예측 2021년-2026년
LPI-2201K02497 / LP Information / 2021년 12월 / 본 조사보고서는 POC HbA1C 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of POC HbA1C Testing will have significant change from previous year. By the most conservative estimates of global POC HbA1C Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 418.7 million in...

세계의 잠재성 결핵감염증 (LTBI) 검사 시장예측 2021년-2026년
LPI-2201K00166 / LP Information / 2021년 12월 / 본 조사보고서는 잠재성 결핵감염증 (LTBI) 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Latent Tuberculosis Infection (LTBI) Testing will have significant change from previous year. By the most conservative estimates of global Latent Tuberculosis Infection (LTBI) Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from...